Clonal evolution is a prognostic factor for the clinical progression of monoclonal B-cell lymphocytosis

Blood Cancer J. 2017 Aug 25;7(8):e597. doi: 10.1038/bcj.2017.77.

Authors

I V Kostopoulos^{1

2}, G Paterakis³, D Pavlidis¹, E Kastritis⁴, E Terpos⁴, O E Tsitsilonis², S I Papadhimitriou¹

Affiliations

¹ Hematology Laboratory, 'G. Gennimatas' Athens General Hospital, Athens, Greece.
² Section of Animal and Human Physiology, Department of Biology, National and Kapodistrian University of Athens, Athens, Greece.
³ Flow Cytometry Laboratory, 'G. Gennimatas' Athens General Hospital, Athens, Greece.
⁴ Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Aged, 80 and over
B-Lymphocytes / metabolism*
B-Lymphocytes / pathology
Disease-Free Survival
Female
Follow-Up Studies
Humans
Lymphocytosis / blood*
Lymphocytosis / mortality*
Lymphocytosis / pathology
Male
Middle Aged
Survival Rate